ATENOLOL INHIBITS THE ELIMINATION OF DISOPYRAMIDE

被引：11

作者：

BONDE, J

BODTKER, S

ANGELO, HR

SVENDSEN, TL

KAMPMANN, JP

机构：

[1] BISPEBJERG HOSP,CLIN CHEM,DK-2400 COPENHAGEN NV,DENMARK

[2] BISPEBJERG HOSP,DEPT INTERNAL MED P,DK-2400 COPENHAGEN NV,DENMARK

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 28卷 / 01期

关键词：

D O I：

10.1007/BF00635706

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：41 / 43

页数：3

共 11 条

[1] DISOPYRAMIDE KINETICS IN RENAL IMPAIRMENT - DETERMINANTS OF INTERINDIVIDUAL VARIABILITY [J].

BURK, M ;

PETERS, U .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (03) :331-340

[2] THE EFFECT OF CONCURRENT ORAL-ADMINISTRATION OF PROPRANOLOL AND DISOPYRAMIDE ON CARDIAC-FUNCTION IN HEALTHY-MEN [J].

CATHCARTRAKE, WF ;

COKER, JE ;

ATKINS, FL ;

HUFFMAN, DH ;

HASSANEIN, KM ;

SHEN, DD ;

AZARNOFF, DL .

CIRCULATION, 1980, 61 (05) :938-945

[3]

CHIANG WT, 1982, BRIT J CLIN PHARMACO, V14, pP590

[4]

CUMMING AD, 1979, BR MED J, V4, P1264

[5] ANTIARRHYTHMIC EFFICACY OF INTRAVENOUS THERAPY WITH DISOPYRAMIDE PHOSPHATE [J].

DEANO, DA ;

WU, D ;

MAUTNER, RK ;

SHERMAN, RH ;

EHSANI, AE ;

ROSEN, KM .

CHEST, 1977, 71 (05) :597-606

[6] STUDIES ON PHARMACOKINETICS AND PHARMACODYNAMICS OF ATENOLOL IN MAN [J].

FITZ GERALD, JD ;

RUFFIN, R ;

SMEDSTAD, KG ;

ROBERTS, R ;

MCAINSH, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 13 (02) :81-89

[7]

GELIPTER D, 1980, BRIT MED J, V1, P52

[8] CLINICAL PHARMACOKINETICS OF DISOPYRAMIDE [J].

KARIM, A ;

NISSEN, C ;

AZARNOFF, DL .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (05) :465-494

[9]

LIMA JJ, 1979, CLIN CHEM, V25, P405

[10] DIFFERENT EFFECTS OF PROPRANOLOL, ALPRENOLOL, SOTALOL, ATENOLOL AND METOPROLOL ON SERUM-T3 AND SERUM-RT3 IN HYPERTHYROIDISM [J].

PERRILD, H ;

HANSEN, JM ;

SKOVSTED, L ;

CHRISTENSEN, LK .

CLINICAL ENDOCRINOLOGY, 1983, 18 (02) :139-142

← 1 2 →